Rajendra Institute of Technology & Sciences, India
Scientific Tracks Abstracts: J Chromatogr Sep Tech
Coronaviruses are a large Coronaviridae family of viruses, which are first identified nearly 60 years ago, they only received notoriety in 2003 when one of their members was identified as the aetiological agent of severe acute respiratory syndrome. In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections (2019-nCoV, COVID-19) detected in Wuhan, the largest metropolitan area in China’s Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019. In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, H1N1 influenza in 2009, and Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 have been recorded. The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk. Every people wants to know in understanding of the mechanisms of coronavirus replication, interactions with the host immune response and disease pathogenesis and what are the recent identification of numerous novel coronaviruses and the propensity of this virus family to cross species barriers. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Currently, SARS-CoV-2 has spread rapidly in multiple countries, caused severe illness and sustained human-to-human transmission, making it a concerning and serious public-health threat.
Dr. Sher Singh has completed his post-graduate in Master of Pharmacy in the Department of Pharmacology at the age of 25 years from Rajendra Institute of Technology & Sciences, Department of Pharmacology, Sirsa – 125055, Haryana (India) under affiliated to pandit BD Sharma university of Health Sciences, Rohtak. He published one review paper in reputed journals. Now he’s in Research of the Technology and Science related outcomes and issues.